Here's the live share price of Boston Bio Systems along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Boston Bio Systems has declined 19.04% CAGR. Over the past year, the corresponding return has been -65.22%.
Boston Bio Systems’s current P/E of -11.00x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Boston Bio Systems | 4.45 | -10.47 | -15.37 | 3.71 | -65.22 | -29.67 | -19.04 |
| Lenskart Solutions | -1.41 | 0.52 | 0.52 | 0.52 | 0.52 | 0.17 | 0.1 |
| Kretto Syscon | 5.26 | -18.7 | -35.9 | -53.65 | -8.48 | 29.05 | 39.48 |
| GKB Ophthalmics | -18.22 | -25 | -32.87 | -34 | -51.73 | -21.99 | -0.04 |
Over the last one year, Boston Bio Systems has declined 65.22% compared to peers like Lenskart Solutions (0.52%), Kretto Syscon (-8.48%), GKB Ophthalmics (-51.73%). From a 5 year perspective, Boston Bio Systems has underperformed peers relative to Lenskart Solutions (0.10%) and Kretto Syscon (39.48%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 7.16 | 7.24 |
| 10 | 6.93 | 7.18 |
| 20 | 7.34 | 7.3 |
| 50 | 7.83 | 7.63 |
| 100 | 7.81 | 8 |
| 200 | 9.08 | 8.96 |
In the latest quarter, Boston Bio Systems remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 97.86% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Nov 27, 2025, 10:39 PM IST | Boston Bio Systems L - Announcement under Regulation 30 (LODR)-Change of Company Name |
| Nov 14, 2025, 7:13 PM IST | Boston Bio Systems L - Considered And Approved The Standalone Un-Audited Financial Results Of The Company For The Quarter And |
| Nov 14, 2025, 7:07 PM IST | Boston Bio Systems L - Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligati |
| Nov 07, 2025, 6:12 AM IST | Boston Bio Systems L - Board Meeting Intimation for Prior Intimation Of Date Of Board Meeting For Considering The Unaudited F |
| Oct 14, 2025, 7:27 PM IST | Boston Bio Systems L - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
Boston Bio Systems Ltd. is a Public Limited Listed company incorporated on 17/04/1995 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L31100GJ1995PLC025476 and registration number is 025476. Currently company belongs to the Industry of Lenses/Optical Care. Company's Total Operating Revenue is Rs. 0.19 Cr. and Equity Capital is Rs. 7.00 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Boston Bio Systems is ₹7.27 as on Dec 04, 2025.
The Boston Bio Systems is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Boston Bio Systems is ₹5.09 Cr as on Dec 04, 2025.
Today’s highest and lowest price of Boston Bio Systems are ₹7.28 and ₹7.27.
The 52-week high/low is the highest and lowest price at which Boston Bio Systems stock has traded in the past 52-week or nearly a year. The 52-week high of Boston Bio Systems is ₹0.00 and 52-week low of Boston Bio Systems is ₹0.00 as on Dec 04, 2025.
The Boston Bio Systems has shown returns of 0.0% over the past day, -14.47% for the past month, -14.27% over 3 months, -65.22% over 1 year, -29.67% across 3 years, and -19.04% over 5 years.
P/E ratio of and PB ratio of Boston Bio Systems are -11.00 and 0.86 on Dec 04, 2025. While the company gives a dividend yield of 0.00 per annum.